Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

被引:567
作者
Barretina, Jordi [2 ,3 ,4 ]
Taylor, Barry S. [1 ,5 ]
Banerji, Shantanu [2 ,3 ,4 ]
Ramos, Alexis H. [2 ,3 ,4 ]
Lagos-Quintana, Mariana [6 ]
DeCarolis, Penelope L. [6 ]
Shah, Kinjal [2 ,4 ]
Socci, Nicholas D. [1 ]
Weir, Barbara A. [2 ,3 ,4 ]
Ho, Alan [7 ]
Chiang, Derek Y. [2 ,3 ,4 ]
Reva, Boris [1 ]
Mermel, Craig H. [2 ,3 ,4 ]
Getz, Gad [4 ]
Antipin, Yevgenyi [1 ]
Beroukhim, Rameen [2 ,3 ,4 ]
Major, John E. [1 ]
Hatton, Charles [2 ,3 ]
Nicoletti, Richard [2 ,3 ]
Hanna, Megan [2 ,3 ]
Sharpe, Ted [4 ]
Fennell, Tim J. [4 ]
Cibulskis, Kristian [4 ]
Onofrio, Robert C. [4 ]
Saito, Tsuyoshi [8 ,9 ]
Shukla, Neerav [8 ,9 ]
Lau, Christopher [8 ,9 ]
Nelander, Sven [1 ]
Silver, Serena J. [4 ]
Sougnez, Carrie [4 ]
Viale, Agnes [10 ]
Winckler, Wendy [2 ,4 ]
Maki, Robert G.
Garraway, Levi A. [2 ,3 ,4 ]
Lash, Alex [1 ]
Greulich, Heidi [1 ,2 ,3 ]
Root, David E. [4 ]
Sellers, William R. [11 ]
Schwartz, Gary K. [7 ]
Antonescu, Cristina R.
Lander, Eric S. [4 ]
Varmus, Harold E. [12 ]
Ladanyi, Marc [8 ,9 ]
Sander, Chris [1 ]
Meyerson, Matthew [2 ,3 ,4 ,13 ]
Singer, Samuel [6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA
[4] Broad Inst MIT & Harvard, Cambridge, MA USA
[5] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, Sarcoma Biol Lab, Sarcoma Dis Management Program, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Lab New Drug Dev, Dept Med, New York, NY 10021 USA
[8] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[9] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[10] Sloan Kettering Inst, Genom Core Lab, New York, NY USA
[11] Novartis Inst Biomed Res, Cambridge, MA USA
[12] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA
[13] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
GASTROINTESTINAL STROMAL TUMORS; HUMAN CANCER GENES; DEDIFFERENTIATED LIPOSARCOMA; ANTAGONIST NUTLIN-3A; PIK3CA GENE; MUTATIONS; CELLS; PATHWAY; P53; CENSUS;
D O I
10.1038/ng.619
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Soft-tissue sarcomas, which result in approximately 10,700 diagnoses and 3,800 deaths per year in the United States(1), show remarkable histologic diversity, with more than 50 recognized subtypes(2). However, knowledge of their genomic alterations is limited. We describe an integrative analysis of DNA sequence, copy number and mRNA expression in 207 samples encompassing seven major subtypes. Frequently mutated genes included TP53 (17% of pleomorphic liposarcomas), NF1 (10.5% of myxofibrosarcomas and 8% of pleomorphic liposarcomas) and PIK3CA (18% of myxoid/round-cell liposarcomas, or MRCs). PIK3CA mutations in MRCs were associated with Akt activation and poor clinical outcomes. In myxofibrosarcomas and pleomorphic liposarcomas, we found both point mutations and genomic deletions affecting the tumor suppressor NF1. Finally, we found that short hairpin RNA (shRNA)-based knockdown of several genes amplified in dedifferentiated liposarcoma, including CDK4 and YEATS4, decreased cell proliferation. Our study yields a detailed map of molecular alterations across diverse sarcoma subtypes and suggests potential subtype-specific targets for therapy.
引用
收藏
页码:715 / U103
页数:9
相关论文
共 55 条
  • [1] Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
    Ambrosini, G.
    Sambol, E. B.
    Carvajal, D.
    Vassilev, L. T.
    Singer, S.
    Schwartz, G. K.
    [J]. ONCOGENE, 2007, 26 (24) : 3473 - 3481
  • [2] Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells
    Ambrosini, Grazia
    Cheema, Haider S.
    Seelman, Sharon
    Teed, Allison
    Sambol, Elliot B.
    Singer, Samuel
    Schwartz, Gary K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 890 - 896
  • [3] Antonescu CR, 2001, CLIN CANCER RES, V7, P3977
  • [4] Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
    Barbareschi, Mattia
    Buttitta, Fiamma
    Felicioni, Lara
    Cotrupi, Sabrina
    Barassi, Fabio
    Del Grammastro, Maela
    Ferro, Antonella
    Palma, Paolo Dalla
    Galligioni, Enzo
    Marchetti, Antonio
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (20) : 6064 - 6069
  • [5] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [6] Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
    Beroukhim, Rameen
    Getz, Gad
    Nghiemphu, Leia
    Barretina, Jordi
    Hsueh, Teli
    Linhart, David
    Vivanco, Igor
    Lee, Jeffrey C.
    Huang, Julie H.
    Alexander, Sethu
    Du, Jinyan
    Kau, Tweeny
    Thomas, Roman K.
    Shah, Kinial
    Soto, Horacio
    Perner, Sven
    Prensner, John
    Debiasi, Ralph M.
    Demichelis, Francesca
    Hatton, Charlie
    Rubin, Mark A.
    Garraway, Levi A.
    Nelson, Stan F.
    Liau, Linda
    Mischel, Paul S.
    Cloughesy, Tim F.
    Meyerson, Matthew
    Golub, Todd A.
    Lander, Eric S.
    Mellinghoff, Ingo K.
    Sellers, William R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) : 20007 - 20012
  • [7] Comprehensive genomic characterization defines human glioblastoma genes and core pathways
    Chin, L.
    Meyerson, M.
    Aldape, K.
    Bigner, D.
    Mikkelsen, T.
    VandenBerg, S.
    Kahn, A.
    Penny, R.
    Ferguson, M. L.
    Gerhard, D. S.
    Getz, G.
    Brennan, C.
    Taylor, B. S.
    Winckler, W.
    Park, P.
    Ladanyi, M.
    Hoadley, K. A.
    Verhaak, R. G. W.
    Hayes, D. N.
    Spellman, Paul T.
    Absher, D.
    Weir, B. A.
    Ding, L.
    Wheeler, D.
    Lawrence, M. S.
    Cibulskis, K.
    Mardis, E.
    Zhang, Jinghui
    Wilson, R. K.
    Donehower, L.
    Wheeler, D. A.
    Purdom, E.
    Wallis, J.
    Laird, P. W.
    Herman, J. G.
    Schuebel, K. E.
    Weisenberger, D. J.
    Baylin, S. B.
    Schultz, N.
    Yao, Jun
    Wiedemeyer, R.
    Weinstein, J.
    Sander, C.
    Gibbs, R. A.
    Gray, J.
    Kucherlapati, R.
    Lander, E. S.
    Myers, R. M.
    Perou, C. M.
    McLendon, Roger
    [J]. NATURE, 2008, 455 (7216) : 1061 - 1068
  • [8] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 472 - 480
  • [9] Somatic mutations affect key pathways in lung adenocarcinoma
    Ding, Li
    Getz, Gad
    Wheeler, David A.
    Mardis, Elaine R.
    McLellan, Michael D.
    Cibulskis, Kristian
    Sougnez, Carrie
    Greulich, Heidi
    Muzny, Donna M.
    Morgan, Margaret B.
    Fulton, Lucinda
    Fulton, Robert S.
    Zhang, Qunyuan
    Wendl, Michael C.
    Lawrence, Michael S.
    Larson, David E.
    Chen, Ken
    Dooling, David J.
    Sabo, Aniko
    Hawes, Alicia C.
    Shen, Hua
    Jhangiani, Shalini N.
    Lewis, Lora R.
    Hall, Otis
    Zhu, Yiming
    Mathew, Tittu
    Ren, Yanru
    Yao, Jiqiang
    Scherer, Steven E.
    Clerc, Kerstin
    Metcalf, Ginger A.
    Ng, Brian
    Milosavljevic, Aleksandar
    Gonzalez-Garay, Manuel L.
    Osborne, John R.
    Meyer, Rick
    Shi, Xiaoqi
    Tang, Yuzhu
    Koboldt, Daniel C.
    Lin, Ling
    Abbott, Rachel
    Miner, Tracie L.
    Pohl, Craig
    Fewell, Ginger
    Haipek, Carrie
    Schmidt, Heather
    Dunford-Shore, Brian H.
    Kraja, Aldi
    Crosby, Seth D.
    Sawyer, Christopher S.
    [J]. NATURE, 2008, 455 (7216) : 1069 - 1075
  • [10] Drug-sensitive FGFR2 mutations in endometrial carcinoma
    Dutt, Amit
    Salvesen, Helga B.
    Chent, Tzu-Hsiu
    Ramos, Alex H.
    Onofrio, Robert C.
    Hatton, Charlie
    Nicoletti, Richard
    Winckler, Wendy
    Grewal, Rupinder
    Hanna, Megan
    Wyhs, Nicolas
    Ziaugra, Liuda
    Richter, Daniel J.
    Trovik, Jone
    Engelsen, Ingeborg B.
    Stefansson, Ingunn M.
    Fennell, Tim
    Cibulskis, Kristian
    Zody, Michael C.
    Akslen, Lars A.
    Gabriel, Stacey
    Wong, Kwok-Kin
    Sellers, William R.
    Meyerson, Matthew
    Greulich, Heidi
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (25) : 8713 - 8717